Long-term outcome with respect to progression-free survival, overall survival, and relapse rate is superior after auto-allo compared with auto only.
Tandem Autologous/Reduced-Intensity Conditioning Allogeneic ...
ascopubs.org › doi › JCO.2010.32.7312
In this trial autologous stem-cell transplantation (auto) followed by reduced-intensity conditioning matched sibling donor allo (auto-allo) was compared with ...
Jun 20, 2013 · Long-term outcome in patients with multiple myeloma was better with auto/RICallo as compared with auto only and the auto/RICallo approach seemed to overcome ...
People also ask
What is the difference between autologous stem cell transplant and allogeneic stem cell transplant?
What is the life expectancy after stem cell transplant for multiple myeloma?
What is a tandem transplant for myeloma?
Who is eligible for ASCT?
Allogeneic hematopoietic cell transplant (HCT) may improve long-term multiple myeloma (MM) control through the graft-versus-myeloma effect.
[PDF] Tandem autologous/reduced-intensity conditioning allogeneic ...
www.semanticscholar.org › paper
Long-term follow up of tandem autologous-allogeneic hematopoietic cell transplantation for multiple myeloma · Medicine. Haematologica · 2018.
Oct 22, 2024 · After a median follow-up of 77 months, the HOVON-50 study showed comparable response rates and survivals between 138 patients without an HLA- ...
Our study showed that tandem autologous/minimal intensity allogeneic HCT for MM was safe and characterized by low acute and long-term toxicities.
Oct 18, 2023 · Autologous followed by allogeneic stem cell transplantation (auto-allo-SCT) has yielded controversial results compared to tandem autologous stem ...
Long-term follow-up of auto-auto versus auto-allo in newly diagnosed multiple myeloma patients confirms significant and durable reduction in risk of relapse.
Nov 20, 2009 · Allogeneic hematopoietic stem cell transplantation with reduced intensity conditioning (RIC) is a controversial treatment in multiple myeloma.